5 Results for "

rad52 inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "rad52 inhibitor" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-124691
CAS No.: 688342-78-1
Purity:  99.70%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

D-I03 is a selective RAD52 inhibitor with a Kd of 25.8 μM. D-I03 specifically inhibits RAD52-dependent single-strand annealing (SSA) and D-loop formation with IC50s of 5 μM and 8 μM, respectively. D-I03 suppresses growth of BRCA1- and BRCA2-deficient cells and inhibits formation of damage-induced RAD52 foci, but does not effect on RAD51 foci induced by Cisplatin .
loading...
    loading...
Cat. No.: HY-110286
CAS No.: 21373-30-8
Purity:  95.23%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

6-Hydroxy-DOPA is a selective and effective allosteric inhibitor of the RAD52 ssDNA binding domain. 6-Hydroxy-DOPA can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-122583
CAS No.: 1225141-73-0
Target:  

RAD51

Research Areas:  

Cancer

D-G23 is a selective RAD52 inhibitor. D-G23 disrupts RAD52-mediated DNA repair pathways and suppresses the growth of BRCA1- and BRCA2-deficient cancer cells. D-G23 is promising for research of homologous recombination-related cancers, such as hereditary breast cancer and ovarian cancer caused by BRCA1/2 mutations .
loading...
    loading...
Cat. No.: HY-153338
CAS No.: 902940-64-1
Research Areas:  

Cancer

C791-0064 is a RAD52 inhibitor. C791-0064 specifically binds to RAD52 and disrupts its single-strand annealing activity. C791-0064 specifically inhibits the proliferation of cancer cells with BRCA2 deficiency, inducing DNA damage and apoptosis (apoptosis). C791-0064 can be used for the study of BRCA mutation-related cancers (such as breast cancer and ovarian cancer) .
loading...
    loading...
Cat. No.: HY-110286R
CAS No.: 21373-30-8
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

6-Hydroxy-DOPA (Standard) is the analytical standard of 6-Hydroxy-DOPA. This product is intended for research and analytical applications. 6-Hydroxy-DOPA is a selective and effective allosteric inhibitor of the RAD52 ssDNA binding domain. 6-Hydroxy-DOPA can be used for the research of cancer .
loading...
    loading...